CD274 and non-small cell lung carcinoma: Although the efficacy of DC and the prognosis of patients with DC according to the proportion of PD-L1 + platelets could not be assessed in the present study, the presence of platelet-derived PD-L1 and PD-L1-expressed circulating platelets might be predictive biomarkers for ICI consolidation in locally advanced NSCLC.